Stock Overview
Beam Therapeutics Inc (BEAM)
NASDAQ · Healthcare · Biotechnology
Beam Therapeutics Inc is a Healthcare company with a market capitalization of $3.58B.
Market Cap
$3.58B
Price/Sales
21.8
Price/Book
3.1
EV/EBITDA
-7.0
Beta
2.20
EPS (TTM)
$-0.49
Profit Margin
-40.2%
ROE
-5.8%
52W High
$36.88
52W Low
$15.60
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$139.74M
Gross Profit
$117.45M
Operating Income
-$383.69M
Net Income
-$79.99M
Free Cash Flow
-$360.05M
Total Debt
$14.36M
Cash & Equivalents
$294.94M
Shareholder Equity
$1.24B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $-0.91 | $-1.01 | +9.9% |
| Q4 2025 | February 24, 2026 | $2.33 | $-1.01 | +330.7% |
| Q3 2025 | November 4, 2025 | $-1.10 | $-1.01 | -8.9% |
| Q2 2025 | August 5, 2025 | $-1.00 | $-1.09 | +8.3% |
| Q1 2025 | May 6, 2025 | $-1.24 | $-1.17 | -6.0% |
| Q4 2024 | February 25, 2025 | $-1.09 | $-1.22 | +10.3% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Beam Therapeutics Inc's market cap?
As of June 29, 2026, Beam Therapeutics Inc (BEAM) has a market capitalization of $3.58B.
Does Beam Therapeutics Inc pay a dividend?
Beam Therapeutics Inc does not currently pay a dividend.
What sector is BEAM in?
Beam Therapeutics Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Beam Therapeutics Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Beam Therapeutics Inc reported revenue of $139.74M and net income of -$79.99M.
Ask your own questions about BEAM
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.